In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
about
Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosisEfficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.Accumulation of norfloxacin by Bacteroides fragilis.In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice.Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs.Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities.
P2860
Q26778064-CB6979BA-5311-4C56-987D-3612AE2B7198Q33689451-BDA66155-90F6-466D-8270-E276A0E23FFEQ33980437-059F9A44-2F4B-4B99-BC7B-71B647C715B9Q33982034-3E26983C-CC3E-49D9-A49D-84DF9493D01FQ35138053-E53A47C3-EA44-46E0-B1F7-AB9A7CD594A8Q35139011-5E5B34D6-404C-4895-9AB9-FFA57EDEDF1BQ40882728-27AAE77D-5BF3-40A9-9361-E4BA7139FECDQ47101582-DA5DD9CB-F3A4-4952-A177-985D3C2330BF
P2860
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
In vivo efficacy of trovafloxa ...... fragilis and Escherichia coli.
@en
In vivo efficacy of trovafloxa ...... fragilis and Escherichia coli.
@nl
type
label
In vivo efficacy of trovafloxa ...... fragilis and Escherichia coli.
@en
In vivo efficacy of trovafloxa ...... fragilis and Escherichia coli.
@nl
prefLabel
In vivo efficacy of trovafloxa ...... fragilis and Escherichia coli.
@en
In vivo efficacy of trovafloxa ...... fragilis and Escherichia coli.
@nl
P2093
P2860
P356
P1476
In vivo efficacy of trovafloxa ...... fragilis and Escherichia coli
@en
P2093
A Esfandiari
F Thadepalli
H Thadepalli
R J Polzer
S Gollapudi
P2860
P304
P356
10.1128/AAC.41.3.583
P407
P577
1997-03-01T00:00:00Z